경카테터 색전 및 폐색 기구 시장 규모, 점유율, 동향 분석 보고서 :제품별, 지역별, 부문별 예측(2025년-2030년)

Transcatheter Embolization And Occlusion Devices Market Growth & Trends:

The global transcatheter embolization and occlusion devices market size is estimated to reach USD 8.54 billion by 2030, registering a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key drivers of the TEO devices market include increasing adoption of minimally invasive surgeries and rising prevalence of cancer.

In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.

Asia Pacific TEO devices market is anticipated to witness highest CAGR, due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices.

Transcatheter Embolization And Occlusion Devices Market Report Highlights:

• In 2024, The non-coil product segment dominated the market with the largest revenue share of 52.3%, propelled by its versatility and effectiveness in a wide range of clinical applications.
• Based product, the coil segment is anticipated to grow at a significant CAGR of 7.0% over the forecast period, driven by its growing application in treating various vascular conditions.
• North America dominated the global market with the largest revenue share of 36.6% in 2024, attributed to the increased adoption of Interventional Radiology (IR) procedures.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Regional Scope
  • 1.2.3. Estimates and Forecasts Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Transcatheter Embolization and Occlusion Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Transcatheter Embolization and Occlusion Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Technological Landscape
    • 3.3.2.3. Economic Landscape

Chapter 4. Transcatheter Embolization and Occlusion Devices Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Transcatheter Embolization and Occlusion Devices Market: Product Movement Analysis
• 4.3. Global Transcatheter Embolization and Occlusion Devices Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
• 4.4. Coil
  • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Pushable Coils
    • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Detachable Coils
    • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.5. Non Coil
  • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Flow Diverting Devices
    • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Embolization Particles
    • 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.4. Liquid Embolics
    • 4.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.5. Other Embolization and Occlusion Devices
    • 4.5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.6. Accessories
    • 4.5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Transcatheter Embolization and Occlusion Devices Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Dashboard
• 5.2. Regional Market Share Analysis, 2024 & 2030
• 5.3. Transcatheter Embolization and Occlusion Devices Market by Region: Key Takeaways
• 5.4. North America
  • 5.4.1. U.S.
    • 5.4.1.1. Key Country Dynamics
    • 5.4.1.2. Regulatory Framework/ Reimbursement Structure
    • 5.4.1.3. Competitive Scenario
    • 5.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Canada
    • 5.4.2.1. Key Country Dynamics
    • 5.4.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.4.2.3. Competitive Scenario
    • 5.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Mexico
    • 5.4.3.1. Key Country Dynamics
    • 5.4.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.4.3.3. Competitive Scenario
    • 5.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.5. Europe
  • 5.5.1. U.K.
    • 5.5.1.1. Key Country Dynamics
    • 5.5.1.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.1.3. Competitive Scenario
    • 5.5.1.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.2. Germany
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.2.3. Competitive Scenario
    • 5.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.3. France
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.3.3. Competitive Scenario
    • 5.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.4. Italy
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.4.3. Competitive Scenario
    • 5.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.5. Spain
    • 5.5.5.1. Key Country Dynamics
    • 5.5.5.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.5.3. Competitive Scenario
    • 5.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.6. Denmark
    • 5.5.6.1. Key Country Dynamics
    • 5.5.6.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.6.3. Competitive Scenario
    • 5.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.7. Sweden
    • 5.5.7.1. Key Country Dynamics
    • 5.5.7.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.7.3. Competitive Scenario
    • 5.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.8. Norway
    • 5.5.8.1. Key Country Dynamics
    • 5.5.8.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.8.3. Competitive Scenario
    • 5.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.6. Asia Pacific
  • 5.6.1. China
    • 5.6.1.1. Key Country Dynamics
    • 5.6.1.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.1.3. Competitive Scenario
    • 5.6.1.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.2. Japan
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.2.3. Competitive Scenario
    • 5.6.2.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.3. India
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.3.3. Competitive Scenario
    • 5.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.4. South Korea
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.4.3. Competitive Scenario
    • 5.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.5. Australia
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.5.3. Competitive Scenario
    • 5.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.6. Thailand
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.6.3. Competitive Scenario
    • 5.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.7. Latin America
  • 5.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7.2. Brazil
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.7.2.3. Competitive Scenario
    • 5.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7.3. Argentina
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.7.3.3. Competitive Scenario
    • 5.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.8. Middle East and Africa
  • 5.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8.2. South Africa
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.2.3. Competitive Scenario
    • 5.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8.3. Saudi Arabia
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.3.3. Competitive Scenario
    • 5.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8.4. UAE
    • 5.8.4.1. Key Country Dynamics
    • 5.8.4.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.4.3. Competitive Scenario
    • 5.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8.5. Kuwait
    • 5.8.5.1. Key Country Dynamics
    • 5.8.5.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.5.3. Competitive Scenario
    • 5.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/ Competition Categorization
• 6.3. Vendor Landscape
  • 6.3.1. Key Company Heat Map Analysis, 2024
• 6.4. Company Profiles
  • 6.4.1. Boston Scientific Corporation
    • 6.4.1.1. Company Overview
    • 6.4.1.2. Financial Performance
    • 6.4.1.3. Product Benchmarking
    • 6.4.1.4. Strategic Initiatives
  • 6.4.2. Terumo Corporation
    • 6.4.2.1. Company Overview
    • 6.4.2.2. Financial Performance
    • 6.4.2.3. Product Benchmarking
    • 6.4.2.4. Strategic Initiatives
  • 6.4.3. Medtronic
    • 6.4.3.1. Company Overview
    • 6.4.3.2. Financial Performance
    • 6.4.3.3. Product Benchmarking
    • 6.4.3.4. Strategic Initiatives
  • 6.4.4. DePuy Synthes (Johnson & Johnson)
    • 6.4.4.1. Company Overview
    • 6.4.4.2. Financial Performance
    • 6.4.4.3. Product Benchmarking
    • 6.4.4.4. Strategic Initiatives
  • 6.4.5. Stryker
    • 6.4.5.1. Company Overview
    • 6.4.5.2. Financial Performance
    • 6.4.5.3. Product Benchmarking
    • 6.4.5.4. Strategic Initiatives
  • 6.4.6. Cordis
    • 6.4.6.1. Company Overview
    • 6.4.6.2. Financial Performance
    • 6.4.6.3. Product Benchmarking
    • 6.4.6.4. Strategic Initiatives
  • 6.4.7. Abbott
    • 6.4.7.1. Company Overview
    • 6.4.7.2. Financial Performance
    • 6.4.7.3. Product Benchmarking
    • 6.4.7.4. Strategic Initiatives
  • 6.4.8. Pfizer Inc.
    • 6.4.8.1. Company Overview
    • 6.4.8.2. Financial Performance
    • 6.4.8.3. Product Benchmarking
    • 6.4.8.4. Strategic Initiatives
  • 6.4.9. Sirtex SIR-Spheres Pty Ltd.
    • 6.4.9.1. Company Overview
    • 6.4.9.2. Financial Performance
    • 6.4.9.3. Product Benchmarking
    • 6.4.9.4. Strategic Initiatives
  • 6.4.10. Nordion (Canada) Inc.
    • 6.4.10.1. Company Overview
    • 6.4.10.2. Financial Performance
    • 6.4.10.3. Product Benchmarking
    • 6.4.10.4. Strategic Initiatives